An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A

Study Identifier
GMA-BTXC-10-001
CT.gov Identifier
NCT01608659
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Facial Aesthetics - Fillers
    • Study Drug
  • botulinum toxin Type A
    • Phase
    N/A
    Sex
    Female
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Previously treated for glabellar lines (hyperfunctional facial lines) with botulinum toxin Type A preparation * Received 2 treatment cycles wtih botulinum toxin Type A (BOTOX®) prior to at least 1 treatment with botulinum toxin Type A (Xeomin®)
    Exclusion Criteria:
    * None

    Protocol Summary

    This is a retrospective chart review to evaluate treatment patterns of botulinum toxin Type A for the treatment of facial lines.

    Study Locations

    Location
    Status
    Location
    Buenos Aires, Argentina
    Status
    Not applicable